Login
$EG
$386.88 -$4.21 (1.08%) Close

Consolidated balance sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
ASSETS:
Fixed maturities - available for sale, at fair value (amortized cost: 2026, $34,912; 2025, $34,620, credit allowances: 2026, $(64); 2025, $(68))
Fixed maturities - held to maturity, at amortized cost (fair value: 2026, $568; 2025, $576, net of credit allowances: 2026, $(8); 2025, $(6))
Equity securities, at fair value
Other invested assets
Short-term investments
Cash
Total investments and cash
Accrued investment income
Premiums receivable (net of credit allowances: 2026, $(99); 2025, $(94))
Reinsurance loss recoverables (net of credit allowances: 2026, $(61); 2025, $(57))
Reinsurance unpaid loss recoverables
Funds held by reinsureds
Deferred acquisition costs
Prepaid reinsurance premiums
Income tax asset, net
Other assets (net of credit allowances: 2026, $(17); 2025, $(17))
TOTAL ASSETS
LIABILITIES:
Reserve for losses and loss adjustment expenses
Future policy benefit reserve
Unearned premium reserve
Funds held under reinsurance treaties
Amounts due to reinsurers
Losses in course of payment
Senior notes
Senior Notes
Total senior notes
Long-term notes
Borrowings from FHLB
Accrued interest on debt and borrowings
Unsettled securities payable
Other liabilities
Total liabilities
SHAREHOLDERS' EQUITY:
Preferred shares, par value: $0.01; 50.0 shares authorized; no shares issued and outstanding
Common shares, par value: $0.01; 200.0 shares authorized; 74.5 (2026) and 74.4 (2025) shares issued and outstanding
Additional paid-in capital
Accumulated other comprehensive income (loss), net of deferred income tax expense (benefit) of $(124) at 2026 and $(23) at 2025
Treasury shares, at cost; 35.8 shares (2026) and 33.7 shares (2025)
Retained earnings
Total shareholders' equity
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support